TearLab Corp  

(Public, NASDAQ:TEAR)   Watch this stock  
Find more results for TEAR
2.59
-0.02 (-0.77%)
Sep 3 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.56 - 2.66
52 week 1.50 - 4.45
Open 2.64
Vol / Avg. 25,153.00/159,998.00
Mkt cap 87.99M
P/E     -
Div/yield     -
EPS -0.86
Shares 33.71M
Beta 3.33
Inst. own 36%
Aug 6, 2015
Q2 2015 TearLab Corp Earnings Call - Webcast
Aug 6, 2015
Q2 2015 Tearlab Corp Earnings Release
Jun 24, 2015
Tearlab Corp at ROTH Healthcare Day - London
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -127.22% -120.31%
Operating margin -121.39% -126.81%
EBITD margin - -111.91%
Return on average assets -94.53% -58.58%
Return on average equity -232.71% -72.16%
Employees 132 -
CDP Score - -

Address

Suite 200, 7360 Carroll Rd
SAN DIEGO, CA 92121
United States - Map
+1-858-4556006 (Phone)
+1-858-8120540 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company is engaged in commercial manufacturing of the TearLab Osmolarity System. The Company's wholly owned subsidiary TearLab Research, Inc. develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites (glucose), genes and proteins) at the point-of-care. The TearLab Osmolarity System measures tear film osmolarity for the diagnosis of Dry Eye Disease (DED). The TearLab Osmolarity System is an integrated testing system consisted of: the TearLab disposable, the TearLab Pen and the TearLab Reader.

Officers and directors

Elias Vamvakas Chairman of the Board, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joseph Jensen President, Chief Operating Officer
Age: 43
Bio & Compensation  - Reuters
Wes Brazell Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Raymond Kong Vice President - Sales
Bio & Compensation  - Reuters
Venkiteshwar Manoj Vice President of Medical Affairs
Age: 37
Bio & Compensation  - Reuters
Paul Smith Vice President - International Markets
Age: 37
Bio & Compensation  - Reuters
Duane Morrison Vice President - Business Development
Age: 51
Bio & Compensation  - Reuters
Anthony E. Altig Independent Director
Age: 59
Bio & Compensation  - Reuters
Thomas N. Davidson Jr. Independent Director
Age: 55
Bio & Compensation  - Reuters
Adrienne L. Graves Ph.D. Independent Director
Age: 61
Bio & Compensation  - Reuters